These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14624942)

  • 1. Effects of simvastatin administration in an experimental model of cancer cachexia.
    Muscaritoli M; Costelli P; Bossola M; Grieco G; Bonelli G; Bellantone R; Doglietto GB; Rossi-Fanelli F; Baccino FM
    Nutrition; 2003; 19(11-12):936-9. PubMed ID: 14624942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interference with tissue hypercatabolism in tumour-bearing rats.
    Tessitore L; Costelli P; Baccino FM
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):71-8. PubMed ID: 8166661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulin.
    Costelli P; Tessitore L; Batetta B; Mulas MF; Spano O; Pani P; Baccino FM; Dessì S
    J Nutr; 1999 Mar; 129(3):700-6. PubMed ID: 10082777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
    Dessì S; Batetta B; Spano O; Bagby GJ; Tessitore L; Costelli P; Baccino FM; Pani P; Argilès JM
    Br J Cancer; 1995 Nov; 72(5):1138-43. PubMed ID: 7577459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of the cytokine suppressive agent FR167653 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
    Busquets S; Alvarez B; van Royen M; Carbó N; López-Soriano FJ; Argilés JM
    Cancer Lett; 2000 Aug; 157(1):99-103. PubMed ID: 10893448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
    Palus S; von Haehling S; Flach VC; Tschirner A; Doehner W; Anker SD; Springer J
    Int J Cardiol; 2013 Oct; 168(4):3412-8. PubMed ID: 23680591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
    Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
    Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cachexia induced by Yoshida ascites hepatoma in Wistar rats is not associated with inflammatory response in the spleen or brain.
    Cernackova A; Mikova L; Horvathova L; Tillinger A; Mravec B
    J Neuroimmunol; 2019 Dec; 337():577068. PubMed ID: 31606594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.
    Penna F; Bonetto A; Aversa Z; Minero VG; Rossi Fanelli F; Costelli P; Muscaritoli M
    J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):345-54. PubMed ID: 27239411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
    Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
    Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the phosphodiesterase-IV inhibitor EMD 95832/3 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
    Meijsing B; Carbó N; López-Soriano FJ; Argilés JM
    Cancer Lett; 2002 Dec; 188(1-2):53-8. PubMed ID: 12406548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth.
    Costelli P; Llovera M; López-Soriano J; Carbó N; Tessitore L; López-Soriano FJ; Baccino FM; Argilés JM
    Cancer Lett; 1995 Oct; 97(1):25-32. PubMed ID: 7585474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals.
    Tessitore L; Costelli P; Bonetti G; Baccino FM
    Arch Biochem Biophys; 1993 Oct; 306(1):52-8. PubMed ID: 8215420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, not glutamine dipeptide, reduces lipases expression and prevents fat wasting and weight loss in Walker 256 tumor-bearing rats.
    de Morais H; de Fatima Silva F; da Silva FG; Silva MO; Graciano MFR; Martins MIL; Carpinelli ÂR; Mazucco TL; Bazotte RB; de Souza HM
    Eur J Pharmacol; 2017 Jul; 806():67-74. PubMed ID: 28390870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
    Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
    Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
    Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
    FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral mediation for cachexia in tumour-bearing rats.
    Tessitore L; Costelli P; Baccino FM
    Br J Cancer; 1993 Jan; 67(1):15-23. PubMed ID: 8427775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia.
    Langstein HN; Doherty GM; Fraker DL; Buresh CM; Norton JA
    Cancer Res; 1991 May; 51(9):2302-6. PubMed ID: 1901758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.